GlaxoSmithKline site provides 1,000 new homes
dha have secured permission for phase 1 of an exciting 173 unit residential regeneration scheme at the former GlaxoSmithKline site in central Dartford.
This site is key to Dartford Town Centre’s wider regeneration plan and phase 1 represents the first stage of development of a vibrant residential district of up to 1050 residential units along with retail, leisure and café /restaurant facilities.
Permission for phase 1 was approved under officers’ delegated powers. The application for phase 2 for 450+ units is to be submitted in June 2014.
For more information please contact Matthew Woodhead.